These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 23207485)

  • 61. Hypothesis: glutaminyl cyclase inhibitors decrease risks of Alzheimer's disease and related dementias.
    Hennekens CH; Bensadon BA; Zivin R; Gaziano JM
    Expert Rev Neurother; 2015; 15(11):1245-8. PubMed ID: 26450764
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Glutaminyl cyclase inhibitor contributes to the regulation of HSP70, HSP90, actin, and ribosome on gene and protein levels in vitro.
    Yu X; Li Y; Zou Y; Zheng Y; He Z; Liu Z; Xie W; Wu H
    J Cell Biochem; 2019 Jun; 120(6):9460-9471. PubMed ID: 30582198
    [TBL] [Abstract][Full Text] [Related]  

  • 63. A patent review of glutaminyl cyclase inhibitors (2004-present).
    Coimbra JRM; Salvador JAR
    Expert Opin Ther Pat; 2021 Sep; 31(9):809-836. PubMed ID: 33896339
    [No Abstract]   [Full Text] [Related]  

  • 64. TNF-related apoptosis-inducing ligand level in Alzheimer's disease.
    Genc S; Egrilmez MY; Yaka E; Cavdar Z; Iyilikci L; Yener G; Genc K
    Neurol Sci; 2009 Jun; 30(3):263-7. PubMed ID: 19294332
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Hydrazides Are Potent Transition-State Analogues for Glutaminyl Cyclase Implicated in the Pathogenesis of Alzheimer's Disease.
    Kupski O; Funk LM; Sautner V; Seifert F; Worbs B; Ramsbeck D; Meyer F; Diederichsen U; Buchholz M; Schilling S; Demuth HU; Tittmann K
    Biochemistry; 2020 Jul; 59(28):2585-2591. PubMed ID: 32551535
    [TBL] [Abstract][Full Text] [Related]  

  • 66. The structure of the human glutaminyl cyclase-SEN177 complex indicates routes for developing new potent inhibitors as possible agents for the treatment of neurological disorders.
    Pozzi C; Di Pisa F; Benvenuti M; Mangani S
    J Biol Inorg Chem; 2018 Dec; 23(8):1219-1226. PubMed ID: 30132075
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Natural Products from Microalgae with Potential against Alzheimer's Disease: Sulfolipids Are Potent Glutaminyl Cyclase Inhibitors.
    Hielscher-Michael S; Griehl C; Buchholz M; Demuth HU; Arnold N; Wessjohann LA
    Mar Drugs; 2016 Nov; 14(11):. PubMed ID: 27827845
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Glutaminyl Cyclase, Diseases, and Development of Glutaminyl Cyclase Inhibitors.
    Xu C; Wang YN; Wu H
    J Med Chem; 2021 May; 64(10):6549-6565. PubMed ID: 34000808
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Glutaminyl cyclases, the potential targets of cancer and neurodegenerative diseases.
    Zhang Y; Wang Y; Zhao Z; Peng W; Wang P; Xu X; Zhao C
    Eur J Pharmacol; 2022 Sep; 931():175178. PubMed ID: 35948163
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Repurposing FDA-Approved Compounds for the Discovery of Glutaminyl Cyclase Inhibitors as Drugs Against Alzheimer's Disease.
    Xu C; Zou H; Yu X; Xie Y; Cai J; Shang Q; Ouyang N; Wang Y; Xu P; He Z; Wu H
    ChemistryOpen; 2021 Sep; 10(9):877-881. PubMed ID: 33377311
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Discovery of potent indazole-based human glutaminyl cyclase (QC) inhibitors as Anti-Alzheimer's disease agents.
    Van Manh N; Hoang VH; Ngo VTH; Kang S; Jeong JJ; Ha HJ; Kim H; Kim YH; Ann J; Lee J
    Eur J Med Chem; 2022 Dec; 244():114837. PubMed ID: 36265279
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Rationale and study design of a randomized, placebo-controlled, double-blind phase 2b trial to evaluate efficacy, safety, and tolerability of an oral glutaminyl cyclase inhibitor varoglutamstat (PQ912) in study participants with MCI and mild AD-VIVIAD.
    Vijverberg EGB; Axelsen TM; Bihlet AR; Henriksen K; Weber F; Fuchs K; Harrison JE; Kühn-Wache K; Alexandersen P; Prins ND; Scheltens P
    Alzheimers Res Ther; 2021 Aug; 13(1):142. PubMed ID: 34425883
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Discovery of Conformationally Restricted Human Glutaminyl Cyclase Inhibitors as Potent Anti-Alzheimer's Agents by Structure-Based Design.
    Hoang VH; Ngo VTH; Cui M; Manh NV; Tran PT; Ann J; Ha HJ; Kim H; Choi K; Kim YH; Chang H; Macalino SJY; Lee J; Choi S; Lee J
    J Med Chem; 2019 Sep; 62(17):8011-8027. PubMed ID: 31411468
    [TBL] [Abstract][Full Text] [Related]  

  • 74.
    Tran PT; Hoang VH; Lee J; Hien TTT; Tung NT; Ngo ST
    RSC Adv; 2019 Sep; 9(51):29619-29627. PubMed ID: 35531555
    [TBL] [Abstract][Full Text] [Related]  

  • 75. A rapid fluorometric assay for N-terminal glutaminyl cyclase activity using high-performance liquid chromatography.
    Consalvo AP; Young SD; Jones BN; Tamburini PP
    Anal Biochem; 1988 Nov; 175(1):131-8. PubMed ID: 3245563
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Basal and activated intracellular calcium ion concentrations in mononuclear cells of Alzheimer's disease and unipolar depression.
    Adunsky A; Diver-Haber A; Becker D; Hershkowitz M
    J Gerontol A Biol Sci Med Sci; 1995 Jul; 50(4):B201-4. PubMed ID: 7614231
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Synthesis and evaluation of [
    Brooks AF; Jackson IM; Shao X; Kropog GW; Sherman P; Quesada CA; Scott PJ
    Medchemcomm; 2015 Jun; 6(6):1065-1068. PubMed ID: 26101580
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Microarray evidence of glutaminyl cyclase gene expression in melanoma: implications for tumor antigen specific immunotherapy.
    Gillis JS
    J Transl Med; 2006 Jul; 4():27. PubMed ID: 16820060
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Glutaminyl cyclase in human cortex: correlation with (pGlu)-amyloid-β load and cognitive decline in Alzheimer's disease.
    Morawski M; Schilling S; Kreuzberger M; Waniek A; Jäger C; Koch B; Cynis H; Kehlen A; Arendt T; Hartlage-Rübsamen M; Demuth HU; Roßner S
    J Alzheimers Dis; 2014; 39(2):385-400. PubMed ID: 24164736
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Human glutaminyl cyclase: Structure, function, inhibitors and involvement in Alzheimer's disease.
    Vijayan DK; Zhang KYJ
    Pharmacol Res; 2019 Sep; 147():104342. PubMed ID: 31288079
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.